Shilajit: mechanism & evidence

What shilajit is

Shilajit is not a plant, a mineral, or a fungus — it is a humic exudate: the slow product of plant and microbial matter compressed and transformed in rock over centuries, seeping from cracks at altitude as a blackish-brown resin. ASCENTIALS sources from the Altai range above 3,000 metres, where the cold and the fulvic-to-humic ratio favour a cleaner, more standardizable material.

By mass, most of shilajit is humic substances and trace minerals. But mass is the wrong lens. The activity concentrates in a small fraction: the low-molecular-weight fulvic acid, the aromatic dibenzo-α-pyrones, and their derivatives.1 A resin's quality is therefore measured by its standardized fulvic percentage and its assay for contaminants — not by the length of the mineral list on a label.

Three things doing the work

Fulvic acid. The principal active fraction. Of the three humic substances — fulvic acid, humic acid, and humin — fulvic acid has the lowest molecular weight (under ~1 kDa) and the highest oxygen content, which is precisely why it is biologically interesting: small enough to cross cell membranes, reactive enough to carry other molecules with it.1

Dibenzo-α-pyrones (DBPs). Small aromatic molecules that travel with the fulvic fraction and are studied as electron carriers with a role in mitochondrial energy transfer. In the review literature, DBPs and fulvic acid are named together as the constituents most responsible for shilajit's reported effects.1

Humic acid. The larger, less-mobile sibling of fulvic acid. It contributes to the carrier behaviour of the whole complex — humic and fulvic acids together have been described as vehicles that can enhance intestinal absorption of the compounds they bind.5

How it plausibly works

Four mechanisms recur across the literature. None is a claim of cure; each is a structure–function description of what the molecules do.

• Chelation. Fulvic acid binds mineral ions into small, ring-shaped complexes — the same coordination chemistry described under chelation. This can make wanted minerals more absorbable, or help escort unwanted metals out.6
• Membrane transport. Low molecular weight lets fulvic acid shuttle its bound cargo across the intestinal wall and into cells — the step that follows chelation.5
• Redox buffering. Fulvic acid both donates and accepts electrons, which is thought to support mitochondrial electron transport and blunt oxidative stress.1
• Mitochondrial support. In isolated mitochondria and in animal fatigue models, standardized shilajit attenuates ATP depletion — the bioenergetic thread that connects the fatigue and performance findings.5

What has been shown in people

The controlled human literature on shilajit is small but real. Two randomized, placebo-controlled trials anchor it, both using purified material at doses in the 250–500 mg/day range.

Endocrine — testosterone in healthy men

In a randomized, double-blind, placebo-controlled trial, healthy men aged 45–55 took 250 mg of purified shilajit twice daily for 90 consecutive days. The treatment group showed significant increases in total and free testosterone and DHEAS relative to placebo, while the gonadotropins LH and FSH were maintained — a pattern consistent with support rather than override of the endocrine axis.2 The effect is real in this population and this window; it is not instant, and it has not been replicated at scale.

Connective tissue — strength retention & collagen

In a double-blind, placebo-controlled trial of 63 physically active men, 8 weeks of standardized shilajit at 500 mg/day (but not 250 mg/day) significantly lowered serum hydroxyproline — a marker of collagen degradation — and helped preserve maximal strength after a fatiguing protocol.3 The dose-dependence is worth stating honestly: the lower dose did not reach significance.

Promising, but not yet human

A larger body of work is preclinical or in vitro. It is where the mechanism is strongest and the caveats are heaviest — animal and cell findings do not transfer automatically to people.

Mitochondrial bioenergetics & fatigue

In a rat model of chronic fatigue, standardized shilajit modulated the hypothalamic–pituitary–adrenal (HPA) stress axis and improved mitochondrial bioenergetics, attenuating the ATP collapse seen under repeated forced-swim stress.5 This is the animal correlate of the human strength/fatigue signal — a plausible bridge, not a proof in people.

Cognition — fulvic acid and tau

A review of shilajit's procognitive potential highlights in-vitro evidence that fulvic acid acts as an anti-aggregation factor for tau protein, alongside antioxidant and anti-inflammatory activity.4 This is an early, mechanistic finding of research interest — not a basis for any claim about cognitive disease, and we make none.

Why purity is the efficacy story

Shilajit's origin is also its liability. Because it forms in rock, raw resin can concentrate lead, arsenic, mercury, and aluminium from the surrounding geology, and unprocessed material may additionally carry mycotoxins and fungal contamination. This is not a fringe concern — it is the central quality question for the category.

The safety literature is consistent on the resolution: properly purified shilajit, dosed sensibly, carries an acceptable heavy-metal profile.1 The mechanism by which fulvic acid binds metals — chelation — is the same chemistry that makes contamination screening non-negotiable.6 Independent testing across the market has repeatedly shown variability between products labelled "purified," which is why a claim is not a substitute for a batch assay.

ASCENTIALS' answer is procedural, not rhetorical: cold-extracted Altai resin, standardized to ≥60% fulvic acid, with a per-batch Certificate of Analysis confirming identity, standardization, and freedom from heavy metals by ICP-MS. Purity is not a marketing tier here; it is the precondition for every effect described above.

Honest timelines

The studied doses cluster at 250–500 mg/day of standardized resin. The effects are not immediate, and the review is explicit about stating that plainly:

• Endocrine (testosterone/DHEAS) — measured over a ~90-day course at 500 mg/day total (250 mg twice daily).2
• Connective tissue / strength retention — measured over ~8 weeks at 500 mg/day; the 250 mg arm did not reach significance.3
• Energy / fatigue — mechanistically supported and reported in reviews, but the strongest bioenergetic data remain preclinical.5

The practical reading: shilajit is a gradual agent. Expectations set on a 90-day curve are honest; expectations set on a single dose are not.

What we don't yet know

• Small samples, few replications. The two anchoring RCTs are modest in size and, as of this review, not widely replicated. The category's own safety review notes how few well-controlled human studies exist.1
• Population narrowness. The endocrine trial studied men 45–55; extrapolation beyond that group is unproven.2
• Mechanism-to-outcome gaps. The mitochondrial and cognitive findings are compelling mechanistically but sit at the preclinical/in-vitro level.45
• Product heterogeneity. Because activity and safety both track with purification and standardization, results from one standardized material may not generalize to another. This is a reason to read the Certificate of Analysis, not the marketing.

Sources, in full

Every inline marker above links here. Grades follow the ledger convention: RCT Review Preclinical.

1. Stohs SJ · Phytother Res · 2014 Review

   Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research 28(4):475–479.

   DOI 10.1002/ptr.5018 · PMID 23733436
2. Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK · Andrologia · 2016 RCT

   Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia 48(5):570–575.

   DOI 10.1111/and.12482 · PMID 26395129
3. Keller JL, Housh TJ, Hill EC, Smith CM, Schmidt RJ, Johnson GO · J Int Soc Sports Nutr · 2019 RCT

   The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition 16(1):3.

   DOI 10.1186/s12970-019-0270-2
4. Carrasco-Gallardo C, Guzmán L, Maccioni RB · Int J Alzheimers Dis · 2012 Review

   Shilajit: a natural phytocomplex with potential procognitive activity. International Journal of Alzheimer's Disease 2012:674142.

   DOI 10.1155/2012/674142 · PMCID PMC3296184
5. Surapaneni DK, et al. · J Ethnopharmacol · 2012 Preclinical

   Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitary–adrenal axis and mitochondrial bioenergetics in rats. Journal of Ethnopharmacology 143(1):91–99.

   DOI 10.1016/j.jep.2012.06.002
6. Flora SJS, Pachauri V · Int J Environ Res Public Health · 2010 Review

   Chelation in metal intoxication. International Journal of Environmental Research and Public Health 7(7):2745–2788.

   DOI 10.3390/ijerph7072745 · PMCID PMC2922724

The compendium entries

Each Codex entry is the short, canonical statement of one term in this review; this monograph is the evidence beneath them.

Go wider